Literature DB >> 35509371

Single-cell multi-omics analysis reveals IFN-driven alterations in T lymphocytes and natural killer cells in systemic lupus erythematosus.

Dominik Trzupek1, Mercede Lee1, Fiona Hamey1, Linda S Wicker1, John A Todd1, Ricardo C Ferreira1.   

Abstract

Background: The characterisation of the peripheral immune system in the autoimmune disease systemic lupus erythematosus (SLE) at the single-cell level has been limited by the reduced sensitivity of current whole-transcriptomic technologies. Here we employ a targeted single-cell multi-omics approach, combining protein and mRNA quantification, to generate a high-resolution map of the T lymphocyte and natural killer (NK) cell populations in blood from SLE patients.
Methods: We designed a custom panel to quantify the transcription of 534 genes in parallel with the expression of 51 surface protein targets using the BD Rhapsody AbSeq single-cell system. We applied this technology to profile 20,656 T and NK cells isolated from peripheral blood from an SLE patient with a type I interferon (IFN)-induced gene expression signature (IFN hi), and an age- and sex- matched IFN low SLE patient and healthy donor.
Results: We confirmed the presence of a rare cytotoxic CD4 + T cell (CTL) subset, which was exclusively present in the IFN hi patient. Furthermore, we identified additional alterations consistent with increased immune activation in this patient, most notably a shift towards terminally differentiated CD57 + CD8 + T cell and CD16 + NK dim phenotypes, and the presence of a subset of recently-activated naïve CD4 + T cells. Conclusions: Our results identify IFN-driven changes in the composition and phenotype of T and NK cells that are consistent with a systemic immune activation within the IFN hi patient, and underscore the added resolving power of this multi-omics approach to identify rare immune subsets. Consequently, we were able to find evidence for novel cellular peripheral biomarkers of SLE disease activity, including a subpopulation of CD57 + CD4 + CTLs. Copyright:
© 2022 Trzupek D et al.

Entities:  

Keywords:  AbSeq; BD Rhapsody; Single-cell RNA-sequencing (scRNA-seq); biomarker; cytotoxic CD4+ T cells (CTLs); multi-omics; systemic lupus erythematosus (SLE); type I interferon (IFN)

Year:  2022        PMID: 35509371      PMCID: PMC9046903.2          DOI: 10.12688/wellcomeopenres.16883.2

Source DB:  PubMed          Journal:  Wellcome Open Res        ISSN: 2398-502X


  26 in total

Review 1.  Systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

Review 2.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Jacques Banchereau; Virginia Pascual
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

3.  Comprehensive Integration of Single-Cell Data.

Authors:  Tim Stuart; Andrew Butler; Paul Hoffman; Christoph Hafemeister; Efthymia Papalexi; William M Mauck; Yuhan Hao; Marlon Stoeckius; Peter Smibert; Rahul Satija
Journal:  Cell       Date:  2019-06-06       Impact factor: 41.582

4.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

Review 5.  Type I IFN system in the development and manifestations of SLE.

Authors:  Keith B Elkon; Alice Wiedeman
Journal:  Curr Opin Rheumatol       Date:  2012-09       Impact factor: 5.006

6.  The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus.

Authors:  João J Oliveira; Sarah Karrar; Daniel B Rainbow; Christopher L Pinder; Pamela Clarke; Arcadio Rubio García; Osama Al-Assar; Keith Burling; Sian Morris; Richard Stratton; Tim J Vyse; Linda S Wicker; John A Todd; Ricardo C Ferreira
Journal:  Arthritis Res Ther       Date:  2018-07-27       Impact factor: 5.156

7.  Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.

Authors:  Jing He; Ruijun Zhang; Miao Shao; Xiaozhen Zhao; Miao Miao; Jiali Chen; Jiajia Liu; Xiaoying Zhang; Xia Zhang; Yuebo Jin; Yu Wang; Shilei Zhang; Lei Zhu; Alexander Jacob; Rulin Jia; Xujie You; Xue Li; Chun Li; Yunshan Zhou; Yue Yang; Hua Ye; Yanying Liu; Yin Su; Nan Shen; Jessy Alexander; Jianping Guo; Julian Ambrus; Xin Lin; Di Yu; Xiaolin Sun; Zhanguo Li
Journal:  Ann Rheum Dis       Date:  2019-09-19       Impact factor: 19.103

8.  MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data.

Authors:  Greg Finak; Andrew McDavid; Masanao Yajima; Jingyuan Deng; Vivian Gersuk; Alex K Shalek; Chloe K Slichter; Hannah W Miller; M Juliana McElrath; Martin Prlic; Peter S Linsley; Raphael Gottardo
Journal:  Genome Biol       Date:  2015-12-10       Impact factor: 13.583

Review 9.  Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease.

Authors:  Carolyn M Nielsen; Matthew J White; Martin R Goodier; Eleanor M Riley
Journal:  Front Immunol       Date:  2013-12-09       Impact factor: 7.561

10.  Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians.

Authors:  Kosuke Hashimoto; Tsukasa Kouno; Tomokatsu Ikawa; Norihito Hayatsu; Yurina Miyajima; Haruka Yabukami; Tommy Terooatea; Takashi Sasaki; Takahiro Suzuki; Matthew Valentine; Giovanni Pascarella; Yasushi Okazaki; Harukazu Suzuki; Jay W Shin; Aki Minoda; Ichiro Taniuchi; Hideyuki Okano; Yasumichi Arai; Nobuyoshi Hirose; Piero Carninci
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-12       Impact factor: 11.205

View more
  1 in total

1.  Accurate Machine Learning Model to Diagnose Chronic Autoimmune Diseases Utilizing Information From B Cells and Monocytes.

Authors:  Yuanchen Ma; Jieying Chen; Tao Wang; Liting Zhang; Xinhao Xu; Yuxuan Qiu; Andy Peng Xiang; Weijun Huang
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.